SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Esmon CT. Crosstalk between inflammation and thrombosis. Maturitas 2004;47: 305314.
  • 2
    Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb 1992;12: 135145.
  • 3
    Esmon CT. The protein C pathway. Chest 2003;124: 26S32S.
  • 4
    Laszik Z, Mitro A, Taylor FB Jr, Ferrell G, Esmon CT. Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation 1997;96: 36333640.
  • 5
    Fukudome K, Ye X, Tsuneyoshi N et al. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med 1998;187: 10291035.
  • 6
    Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 1996;93: 1021210216.
  • 7
    Esmon CT. The endothelial protein C receptor. Curr Opin Hematol 2006;13: 382385.
  • 8
    Zecchina G, Bosio S, Brusa E, Rege-Cambrin G, Camaschella C. Epcr 23 bp insertion in a patient with severe progressive arterial disease: a dominant loss of function mutant in conditions of increased APC request Br J Haematol 2002;119: 881882.
  • 9
    Biguzzi E, Merati G, Liaw PC et al. A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost 2001;86: 945948.
  • 10
    Akar N, Gökdemir R, Ozel D, Akar E. Endothelial cell protein C receptor (EPCR) gene exon III, 23 bp insertion mutation in the Turkish pediatric thrombotic patients. Thromb Haemost 2002;88: 10681069.
  • 11
    Kendirli T, Ciftçi E, Ince E et al. Homozygous 23-bp insertion of endothelial protein c receptor gene in a child with fatal sepsis. Pediatr Hematol Oncol 2007;24: 199204.
  • 12
    Hiura M, Kikuchi T, Nagasaki K, Uchiyama M. Elevation of serum C-reactive protein levels is associated with obesity in boys. Hypertens Res 2003;26: 541546.
  • 13
    Mauras N, Delgiorno C, Kollman C et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 2010;95: 10601068.
  • 14
    Eichinger S, Hron G, Bialonczyk C et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 2008;168: 16781683.
  • 15
    Butler MG, Bittel DC, Kibiryeva N, Garg U. C-reactive protein levels in subjects with Prader-Willi syndrome and obesity. Genet Med 2006;8: 243248.
  • 16
    Goldstone AP, Thomas EL, Brynes AE et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 2001;86: 43304338.
  • 17
    Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet 2005;67: 230239.
  • 18
    Whittington JE, Holland AJ, Webb T et al. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001;38: 792798.
  • 19
    Tauber M, Diene G, Molinas C, Hébert M. Review of 64 cases of death in children with Prader-Willi syndrome (PWS). Am J Med Genet A 2008;146: 881887.
  • 20
    Grugni G, Crinò A, Bosio L et al.; Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology (ISPED). The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. Am J Med Genet A 2008;146: 861872.
  • 21
    Einfeld SL, Kavanagh SJ, Smith A et al. Mortality in Prader-Willi syndrome. Am J Ment Retard 2006;111: 193198.
  • 22
    Patel S, Harmer JA, Loughnan G et al. Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Clin Endocrinol (Oxf) 2007;66: 771777.
  • 23
    L'Allemand D, Eiholzer U, Schlumpf M, Steinert H, Riesen W. Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome. Eur J Pediatr 2000;159: 835842.
  • 24
    Eiholzer U, Lee PDK. Medical considerations in Prader-Willi syndrome. In: Butler MG, Lee PDK, Whitman BY (eds). Management of Prader-Willi Syndrome, 3rd edn. Springer: New York, 2006, pp 97152.
  • 25
    Lamb AS, Johnson WM. Premature coronary artery atherosclerosis in a patient with Prader-Willi syndrome. Am J Med Genet 1987;28: 873880.
  • 26
    Page SR, Nussey SS, Haywood GA, Jenkins JS. Premature coronary artery disease and the Prader-Willi syndrome. Postgrad Med J 1990;66: 232234.
  • 27
    Gourash LM, Hanchett JE, Forster JL. Inpatient crisis intervention for persons with Prader-Willi syndrome. In: Butler MG, Lee PDK, Whitman BY (eds). Management of Prader-Willi syndrome. 3rd edn. Springer: New York, 2006, pp 395425.
  • 28
    Holm VA, Cassidy SB, Butler MG et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91: 398402.
  • 29
    Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320: 12401243.
  • 30
    Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv Data 2000;8: 127.
  • 31
    Zipf WB. Prader-Willi syndrome: the care and treatment of infants, children, and adults. Adv Pediatr 2004;51: 409434.
  • 32
    Viardot A, Sze L, Purtell L et al. Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. J Clin Endocrinol Metab 2010;95: 33923399.
  • 33
    Höybye C. Inflammatory markers in adults with Prader-Willi syndrome before and during 12 months growth hormone treatment. Horm Res 2006;66: 2732.
  • 34
    Caixàs A, Giménez-Palop O, Broch M et al. Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects. J Endocrinol Invest 2008;31: 169175.
  • 35
    Brambilla P, Crinò A, Bedogni G et al. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. Nutr Metab Cardiovasc Dis 2011;21: 269276.
  • 36
    Nan B, Yang H, Yan S et al. C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Surgery 2005;138: 212222.
  • 37
    Spronk HM, van der Voort D, Ten Cate H. Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J 2004;2: 12.